BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2
98 results:

  • 1. A rare KMT2A::cbl transcript in an acute monoblastic leukemia patient with an unfavorable outcome.
    Yu J; Song F; Zhang M; Xiao P; Feng J; Hong R; Hu Y; Huang H; Wei G
    Mol Biol Rep; 2024 Apr; 51(1):561. PubMed ID: 38643442
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Three-Dimensional Multimodality Image Reconstruction as Teaching Tool for Case-based learning among medical postgraduates: a focus on primary pelvic bone Tumour Education.
    Hu X; Wang Y; Li J; Qing P; Yang X; Zeng J; Min L; Tu C
    BMC Med Educ; 2023 Dec; 23(1):944. PubMed ID: 38087270
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long term outcome of surgical treatment of chondroblastoma: analysis of local control and growth plate/articular cartilage related complications.
    Muratori F; Scanferla R; Roselli G; Frenos F; Campanacci DA
    BMC Musculoskelet Disord; 2023 Feb; 24(1):139. PubMed ID: 36814214
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
    Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
    Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
    Eckardt JN; Stasik S; Röllig C; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Cerqueira T; Kroschinsky F; Berdel WE; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Siepmann T; Bornhäuser M; Middeke JM; Thiede C
    Blood Cancer J; 2023 Jan; 13(1):18. PubMed ID: 36693840
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
    Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
    Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Radiographic assessment of deproteinized bovine bone mineral (DBBM) and collagen-stabilized DBBM for transalveolar sinus floor elevation: A 2-year retrospective cohort study.
    Wu Y; Xiao P; Xu A; He F
    Clin Implant Dent Relat Res; 2022 Apr; 24(2):176-187. PubMed ID: 35167179
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape.
    Tefferi A; Gangat N; Pardanani A; Crispino JD
    Cancer Res; 2022 Mar; 82(5):749-763. PubMed ID: 34911786
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
    Lafage-Pochitaloff M; Gerby B; Baccini V; Largeaud L; Fregona V; Prade N; Juvin PY; Jamrog L; Bories P; Hébrard S; Lagarde S; Mansat-De Mas V; Dovey OM; Yusa K; Vassiliou GS; Jansen JH; Tekath T; Rombaut D; Ameye G; Barin C; Bidet A; Boudjarane J; Collonge-Rame MA; Gervais C; Ittel A; Lefebvre C; Luquet I; Michaux L; Nadal N; Poirel HA; Radford-Weiss I; Ribourtout B; Richebourg S; Struski S; Terré C; Tigaud I; Penther D; Eclache V; Fontenay M; Broccardo C; Delabesse E
    Blood Adv; 2022 Jan; 6(2):386-398. PubMed ID: 34638130
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions.
    Hui M; Uppin SG; Kumar KK; Radhika S; Chandrasekhar P; Rao KN
    Turk Patoloji Derg; 2022; 38(1):9-15. PubMed ID: 34514571
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
    Martin ES; Ferrer A; Mangaonkar AA; Khan SP; Kohorst MA; Joshi AY; Hogan WJ; Olteanu H; Moyer AM; Al-Kali A; Tefferi A; Chen D; Wudhikarn K; Go R; Viswanatha D; He R; Ketterling R; Nguyen PL; Oliveira JL; Gangat N; Lasho T; Patnaik MM
    Am J Hematol; 2021 Nov; 96(11):1450-1460. PubMed ID: 34390506
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents.
    Park HS; Son BR; Shin KS; Byeon S; Kim HK; Yang Y; Jeong Y; Han HS; Lee KH; Kwon J
    Acta Haematol; 2021; 144(6):649-659. PubMed ID: 34233332
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
    Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
    ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial.
    Stouten V; Westhovens R; De Cock D; Van der Elst K; Pazmino S; Bertrand D; Joly J; Verschueren P
    Rheumatology (Oxford); 2021 Aug; 60(8):3699-3708. PubMed ID: 33434277
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk factors for osteonecrosis of the femoral head in brain tumor patients receiving corticosteroid after surgery.
    Lim SJ; Yeo I; Park CW; Lee H; Park YS; Lee JI
    PLoS One; 2020; 15(9):e0238368. PubMed ID: 32881966
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cervical spine osteoradionecrosis or bone metastasis after radiotherapy for nasopharyngeal carcinoma? The MRI-based radiomics for characterization.
    Zhong X; Li L; Jiang H; Yin J; Lu B; Han W; Li J; Zhang J
    BMC Med Imaging; 2020 Sep; 20(1):104. PubMed ID: 32873238
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Spontaneous Rib Fractures After Breast cancer Treatment Based on bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
    Kim DW; Kim JS; Kim K; Shin KH
    Clin Breast Cancer; 2021 Feb; 21(1):e80-e87. PubMed ID: 32800490
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
    Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
    BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.